Highlights from the clinical symposium on Shiga toxin-producing Escherichia coli / haemolytic uremic syndrome, Berlin, September 2011

A Jansen

doi:10.2807/ese.16.39.19977-en

Meeting reports Open Access

Like 0

Download

Highlights from the clinical symposium on Shiga toxin-producing Escherichia coli / haemolytic uremic syndrome, Berlin, September 2011
A Jansen¹
View Affiliations Hide Affiliations

Affiliations: ¹ European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

Correspondence:
A Jansen
andreas.jansen ecdc.europa.eu
View Citation Hide Citation

Citation style for this article: Jansen A. Highlights from the clinical symposium on Shiga toxin-producing Escherichia coli / haemolytic uremic syndrome, Berlin, September 2011. Euro Surveill. 2011;16(39):pii=19977. https://doi.org/10.2807/ese.16.39.19977-en Received: 23 Sept 2011

Abstract

On 9 September 2011, the Estrel Convention Center in Berlin was the venue for a first clinical symposium on Shiga toxin-producing Escherichia coli / haemolytic uremic syndrome (STEC/HUS) reflecting on the large STEC outbreak in Germany earlier this year. The German Society of Nephrology (DGfN) invited internationally renowned clinical experts and microbiologists to discuss the basic science and diagnostics of STEC infections and the different options for treating an EHEC-associated HUS, including plasmapheresis, antibody therapy with Eculizumab, and extracorporeal immune adsorption.